UM-MINTS

Total investments

1

Average round size

8M

Portfolio companies

1

Areas of investment
Surgical DevicesOther Healthcare Technology SystemsHealth CareMedical DeviceMedical

Summary

Among the most successful fund investment fields, there are Therapeutics, Health Care. Among the various public portfolio startups of the fund, we may underline HistoSonics Besides, a startup needs to be aged 6-10 years to get the investment from the fund.

The high activity for fund was in 2017. The common things for fund are deals in the range of 5 - 10 millions dollars. The fund is constantly included in less than 2 deals per year.

The standard case for the fund is to invest in rounds with 8 partakers. Despite the UM-MINTS, startups are often financed by Venture Investors, Grand Angels, Capital Community Angel Investors. The meaningful sponsors for the fund in investment in the same round are Wolverine Venture Fund, Venture Investors, TGap Ventures. In the next rounds fund is usually obtained by Venture Investors, Varian Medical Systems, Lumira Ventures.

Show more

Investments analytics

Analytics

Total investments
1
Lead investments
0
Investments by industry
  • Other Healthcare Technology Systems (1)
  • Health Care (1)
  • Medical Device (1)
  • Surgical Devices (1)
  • Medical (1)
Investments by region
  • United States (1)
Peak activity year
2017

Discover reliable insights

Leverage validated data, identify key contacts and secure funding opportunities for your business.

Quantitative data

Avg. startup age at the time of investment
12
Group Appearance index
1.00

Need more data?

Get access to full data about investors, including their team, contact information, and historic data.

Latest deals

Company name Deal date Industry Deal stage Deal size Location
HistoSonics 13 Mar 2017 Surgical Devices, Other Healthcare Technology Systems, Health Care, Medical Device, Medical Early Stage Venture 8M United States, Minnesota
How we get our data

At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).

Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.